updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
sinc spin baxter
demonstr know stick knit tissu heart
valv edward remain domin forc surgic heart
valv minim invas valv therapi -- one hottest
area cardiac devic
edward done good job refocus higher-margin
product churn meaning innov effort
result impress gross margin
improv sinc becom stand-alon compani although
firm significantli smaller close competitor
abbott term sale remain global leader core
busi tissu heart valv command
global market firm maintain leadership posit
critical-car monitor equip complement heart valv
edward regularli engag serial acquisit
firm recent made seri purchas transcathet mitral
valv technolog order get jump next wave
innov firm remain lead edg come
transcathet aortic heart valv dual aortic franchis
balloon-expand self-expand valv
edward robust transcathet aortic valv pipelin also
lead develop transcathet mitral product edward
pois ride wave new technolog shift valv
replac transcathet approach especi
clinic data support efficaci safeti product
condit
said still anticip bump road
edward alreadi taken shot transcathet mitral valv
littl success challeng area given
econom behind
transcathet aortic valv replac remain less attract
surgic valv mani hospit though eas
market also becom crowd
abbott fray nonetheless think
long-term clinic trend shift toward transcathet
technolog edward sit pretti
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
spun design
manufactur market rang medic devic equip
advanc stage heart diseas key product includ surgic tissu
heart valv transcathet valv technolog surgic clip cathet
retractor monitor system use measur patient heart
function surgeri firm deriv total sale
outsid
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
substanti increas fair valu estim
per share incorpor estim
new stream revenu emerg
transcathet mitral tricuspid valv technolog
europ clear pascal mitral repair
cardioband mitral tricuspid use project
tmtt portfolio reach million revenu
driven product assum regulatori
clearanc food drug administr
probabl evoqu transcathet mitral
replac devic approv
tavr remain largest driver valuat
assum low midteen growth sapien centera
revenu reflect anticip indic
expans includ low-risk patient base
consist favor clinic data come edward
trial among group patient
addit intermediate- low-risk patient would
expand patient pool roughli
importantli think edward eventu captur
subseg high-risk surgic patient
intermediate-risk patient low-risk patient
base avail clinic data expect oper
margin hold steadi around effici
gener off-set price pressur competitor enter
market edward balanc invest
support burgeon transcathet mitral tricuspid
technolog pipelin expect sapien growth
recent strength
next-gener launch new clinic data could sway
practition toward sapien entranc new
competitor
account
transcathet aortic mitral tricuspid valv
franchis drive averag annual top-lin growth
edward slightli higher
previous assum
domest price pressur exacerb
expect new entrant emerg may need revisit
assumpt year total think
increas
compound annual versu
incom
base rel narrow concentr product
portfolio edward rate firm uncertainti high
competitor falter
recogn may substanti upsid patient
pool tavr expand includ intermediate-
low-risk patient addit competit europ remain
peripher
develop
transcathet mitral tricuspid devic case
sketch bull scenario abbott boston
unabl grow major tavr rival
unabl address heart-rhythm complic associ
corevalv condit would drive tavr sale
roughli billion oper margin would
hover averag annual revenu
growth adjust earn growth
scenario bring fair valu estim per
hand see share loss abbott
boston scientif along
aggress price pressur -- expect growth
transcathet aortic valv sale also assum
evoqu never receiv regulatori approv
oper margin peak assumpt
would see top-lin growth price pressur
requir invest research develop
would keep earn growth averag would
slice valuat per share
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
implant mean estim half one third
elderli patient need valv replac
frail high-risk undergo surgic valv replac
believ edward bolster leadership posit
tissu heart valv sapien transcathet aortic valv
franchis tavr deliv either
femor arteri similar angioplasti small
hole two rib minim invas therapi
would potenti tap estim american
patient current
inoper high-risk
candid tradit valv surgeri technolog
wide adopt patient pool expand
includ intermediate-risk patient time trial
data amass new low-risk patient data expect
anticip firm expand tavr
indic fuel growth
edward also firmli set sight tackl larger
challeng develop transcathet mitral valv repair
replac option estim moati tmv
market could rang billion billion
thank greater incid mitral valv diseas edward
work least four differ repair replac
platform firm recent receiv european
regulatori clearanc two transcathet mitral
stand behind stabl moat trend rate
edward expect continu technolog innov
help counter grow threat competit
edward global leader surgic tissu heart valv
less invas technolog put ahead
competitor edward two-year lead pioneer
categori transcathet heart valv -- one hottest
develop excit intervent cardiologist
heart surgeon alik addit edward alreadi
launch next-gener sapien ultra well
despit compet rather matur surgic heart valv
market come domin tissu
valv introduct key transcathet aortic valv
technolog sinc grown billion global
market thu dig narrow moat compani
long histori pioneer new heart valv still highli
regard cardiac surgeon technolog advanc
edward compet abbott primarili mechan heart
valv boston scientif howev
edward remain heavi hitter tissu valv
segment like mani devic compani edward
compet basi technolog
intellectu properti close
relationship
last decad edward focus
technolog given heart valv market jolt
develop minim invas aortic heart valv
instal cathet therebi make
procedur recoveri much easier patient current
tradit valv requir extens surgic procedur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
consist improv upon transcathet product
enhanc make even thinner easier
faster use virtual elimin sever valve-leakag
complic affect patient
earlier technolog compani success
develop transcathet mitral valv technolog think
transcathet valv
everywher formid competitor
key geographi includ abbott
present europ enter
 next year two despit edward head start
geographi firm need offer
meaning innov regular basi keep
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oedward effort focu effici higher-
margin product paid gross margin
increas
ocardiothorac surgeon fairli conserv
bunch like stick proven devic brand
pioneer heart valv edward continu
seen gold standard
oedward benefit age popul
experi problem heart valv
congest heart failur greater frequenc
oedward ambit diversifi
minim
invas medic technolog place firm direct
competit much larger competitor
abbott easili bid price
emerg technolog edward
ocompetit abbott like
enter market start late
oif sapien price remain high even entranc
new rival payer may limit usag transcathet
valv intermediate-risk low-risk patient
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
resourc
edward light debt leverag larg cash invest
posit give firm financi flexibl end
decemb edward major debt outstand
consist roughli million senior unsecur note
matur mean time firm sat
million cash invest follow
recent cardiaq valtech acquisit bolster
mitral valv pipelin gross debt/ebitda stood well
time interest coverag time
view share repurchas like use
manag indic prudent prefer make
repurchas time share look attract
valu marketplac howev recogn
edward share consist ran ahead intrins
valu opportun repurchas share attract
valuat far
million repurchas compani pay
dividend merger acquisit strategi also remain
research develop effort smaller acquisit
expand product offer
purchas
technolog edward ride high growth wave
transcathet aortic valv expect abl
easili fund growth support strateg acquisit
financi resourc cash flow unless
firm becom enamor
opportun someth view unlik
anticip major chang easili manag capit
base rel narrow concentr product
portfolio edward rate firm uncertainti
high volum edward heart valv still requir
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
major surgeri implant medic industri
move toward minim invas procedur
cut recoveri time cost although edward
current enjoy duopoli transcathet aortic valv
 new competitor
horizon still resolv issu
lotu transcathet valv recent acquir new
self-expand tavr technolog expect boston
launch lotu valv year recogn
firm prove fierc competitor
cardiac devic market clinic outcom sapien
valv much longer term yet assess
durabl product meet exceed track
record surgic valv clinician may wari use
product
younger patient addit
preliminari data hint substanti portion
elderli patient popul would expir anyway
independ caus within sever year even
implant sapien valv rais question
medicar appetit reimburs expens devic
put pressur tavr manufactur demonstr
econom valu technolog final edward could
see competit surgic tool busi
minim invas surgic system maker
intuit surgic enter cardiac surgeri market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
michael mussallem ceo/chairman board/
repres date owner name posit common share held report holder issuer
new york mellon corp
capit research manag compani
america corpor
share
fund
share
fund
think edward stewardship exemplari previous
group vice presid baxter michael mussallem
ceo chairman edward sinc spin-off
offer steadi presenc helm mussallem receiv
reason compens like goal
bonu place emphasi revenu growth free
cash flow growth net incom also taken
consider think often subject
would like see even greater detail specif
measur mussallem judg would prefer
see free cash flow gener weight heavili
net incom growth pleas edward reli
restricted-stock unit vest five year rather
stock option alon encourag mussallem
manag edward eye toward longer term
like succession-plan updat provid
board meet ensur board highli involv
survey manag talent potenti execut
posit think firm overal corpor govern
polici well design
corporate-alloc standpoint edward made
wise decis unlik larger rival edward
reli heavili serial acquisit instead
first prioriti plow resourc intern innov
kept surgic heart valv busi
leadership posit support consist
meaning innov transcathet aortic valv
portfolio one major earli acquisit edward made
percutan valv million
includ mileston payment laid
foundat edward sapien technolog addit
pvt catapult edward race enter tavr
market first edward might lucki
purchas mani early-stag technolog
end gutter ball nevertheless edward enjoy
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
strong posit categori project grow
billion edward recent acquisit cardiaq
harpoon valtech bolster firm invest
transcathet mitral valv therapi even though
commerci technolog could take year
think edward strong posit pursu market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
new tavr clinic data provid potenti
impress although necessarili surpris
favor clinic data support use
transcathet aortic valv low-risk patient reveal
late-break session annual american colleg
cardiolog meet edward
lifesci alreadi assum penetr
tavr product patient segment result
leav fair valu wide moat intact
howev plan rais fair valu narrow-moat
edward lifesci incorpor project
transcathet mitral tricuspid product
valuat emerg technolog
secur regulatori approv europ may also
consid turn edward moat trend posit make
progress develop commerci rang
consist data intermediate-risk patient tavr
least compar surgic valv replac among
low-risk popul medtron corevalv evolut
demonstr non-inferior surgeri think
pave way addit indic edward went
one step demonstr sapien superior
tradit surgic valv replac among low-risk
patient base rate death stroke
rehospit one year expect strength
latest sapien data translat substanti
penetr low-risk patient pool also think
data reinforc edward manag current strategi
hold price last year result
eros market share convers clinic result may
put price pressur seek protect
market share believ grow amount
consist favor clinic data edward could also
make difficult break
third place relaunch lotu year
surpris chang fair valu estim feb
gener line expect dont
anticip materi chang fair valu estim
make slight adjust beyond sale
transcathet aortic valv full year close
expect howev surgic heart valv fell short
estim off-set robust perform
critic care enjoy robust adopt next-
gener monitor platform adjust
legal settlement boston scientif
impair charg relat valtech acquisit
fourth-quart oper incom earn slightli
exceed project unfortun rival abbott
pursu edward intellectu properti litig
certain market earli tell relat
financi implic might could see unfold
next year remain confid edward narrow
econom moat clinic data associ
edward competit transcathet mitral valv
technolog begin dribbl time
period may consid turn edward moat trend
posit data favor firm continu
maintain lead develop technolog
although growth tavr sale moder edward
still expect expans patient pool support low-
double-digit growth anticip see
favor data trial share
cardiolog confer next month put edward
track low-risk indic year-end stick
expect low-single-digit growth surgic
valv like rais estim faster growth
critic care roughli million transcathet
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
mitral valv sale though materi shift
final particularli worri tavr share
declin edward absorb stem
mainli firm decis stand premium
price manag estim sapien franchis lost
roughli basi point market share last year
perspect alarm addit
firm alreadi teed next-gen sapien ultra
receiv european regulatori approv late
base weve seen past new sapien
platform roll anticip posit recept
practition help edward eke back share
rule unconstitut district court
near-term impact fundament dec
dec judg reed connor northern district
texa issu rule effect declar patient
protect afford act
unconstitut assum littl chang
compani cover healthcar sector
near term rule like make way
appeal process surpris see
case third appear make front
 suprem court potenti timelin final
basi decis find root congress
elimin shared-respons financi penalti
accompani passag tax cut job act
late last year short judg connor found individu
mandat essenti insever provis
congress decis elimin enforc
tax penalti law render entireti
legisl unconstitut logic follow
 suprem court decis upheld
constitut congress power taxat
view healthcar provid sector at-risk
stem chang prevail healthcar
legisl whether chang individu coverag
roll-back medicaid expans higher uninsur
rate unequivoc equat pressur hospit margin
payer perspect trade-off littl less clear
although medicaid-focus insur like feel
bulk enrol loss
intend make chang moat rate fair
valu estim result decis continu
monitor case make way appel
court come month outcom timelin
uncertain make meaning chang
assumpt earli day addit wildcard
potenti legisl action muddi
ultim financi penalti carri
insur coverag set end jan
understand feder govern intend
maintain statu quo appeal process
insur alreadi lock rate propos
earliest like see potenti effect
rule premium polici offer slate
open enrol season
edward lifesci continu support robust
invest transcathet mitral valv program
gener met expect top bottom
line havent shift project
moder tavr growth reflect key dynam includ
matur market entranc addit
competitor market likelihood
indic expans reach low-risk patient plan
modestli rais fair valu account cash flow
realiz sinc last updat weve long fan
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
compani narrow econom moat propens invest
meaning innov manag abil
consist achiev commerci success howev
less enamor share often
trade -- significantli intrins valu estim
see sign tavr growth settl
mid-teen growth believ premium could shrink
hand edward make quicker progress
variou program develop transcathet mitral valv
technolog address much larger market could
also see share rise loftier level yet
incorpor estim edward tmv repair
replac product pipelin
remain rel earli stage clinic studi well
revisit issu edward set begin enrol
pascal pivot trial follow clinic data
coapt trial releas transcathet cardiovascular
therapeut fall suggest competit product
mitraclip effect rehospit mortal
two year among patient function mitral
detail discuss transcathet mitral
valv market competitor pursu develop pleas
see report chang heart renew interest among
cardiac devic maker transcathet mitral valv
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
